0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Colorectal Cancer Drugs Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-12H7528
Home | Market Reports | Health| Health Conditions| Cancer
Global Colorectal Cancer Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Colorectal Cancer Drugs Market Research Report 2023

Code: QYRE-Auto-12H7528
Report
November 2023
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Colorectal Cancer Drugs Market Size

According to new survey, global Colorectal Cancer Drugs market is projected to reach US$ 434 million in 2029, increasing from US$ 349 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029.

Colorectal Cancer Drugs Market

Colorectal Cancer Drugs Market

There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Colorectal Cancer Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Colorectal Cancer Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Colorectal Cancer Drugs Market Report

Report Metric Details
Report Name Colorectal Cancer Drugs Market
Accounted market size in 2022 US$ 349 million
Forecasted market size in 2029 US$ 434 million
CAGR 3.6%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Vascular Endothelial Growth Factor (VEGF) Inhibitors
  • Epidermal Growth Factor Receptor (EGFR) Inhibitors
  • Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
  • BRAF or MEK Inhibitors
  • Tyrosine Kinase (TKI) Inhibitors
  • Immunomodulators
Segment by Application
  • Radiotherapy
  • Chemotherapy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AB Science, Amgen, Array BioPharma, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Elli Lilly, Roch, Hutchison MediPharma, Merck & Co., Inc., Mologen, Regeneron, Sanofi, Sumitomo Dainippon, Taiho Pharmaceutical, Vaccinogen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Colorectal Cancer Drugs Market growing?

Ans: The Colorectal Cancer Drugs Market witnessing a CAGR of 3.6% during the forecast period 2023-2029.

What is the Colorectal Cancer Drugs Market size in 2029?

Ans: The Colorectal Cancer Drugs Market size in 2029 will be US$ 434 million.

Who are the main players in the Colorectal Cancer Drugs Market report?

Ans: The main players in the Colorectal Cancer Drugs Market are AB Science, Amgen, Array BioPharma, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Elli Lilly, Roch, Hutchison MediPharma, Merck & Co., Inc., Mologen, Regeneron, Sanofi, Sumitomo Dainippon, Taiho Pharmaceutical, Vaccinogen

What are the Application segmentation covered in the Colorectal Cancer Drugs Market report?

Ans: The Applications covered in the Colorectal Cancer Drugs Market report are Radiotherapy, Chemotherapy

What are the Type segmentation covered in the Colorectal Cancer Drugs Market report?

Ans: The Types covered in the Colorectal Cancer Drugs Market report are Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators

1 Colorectal Cancer Drugs Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Drugs
1.2 Colorectal Cancer Drugs Segment by Type
1.2.1 Global Colorectal Cancer Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Colorectal Cancer Drugs Segment by Application
1.3.1 Global Colorectal Cancer Drugs Market Value by Application: (2023-2029)
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Global Colorectal Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Colorectal Cancer Drugs Revenue 2018-2029
1.4.2 Global Colorectal Cancer Drugs Sales 2018-2029
1.4.3 Global Colorectal Cancer Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Colorectal Cancer Drugs Market Competition by Manufacturers
2.1 Global Colorectal Cancer Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Colorectal Cancer Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Colorectal Cancer Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Colorectal Cancer Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Colorectal Cancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Colorectal Cancer Drugs, Product Type & Application
2.7 Colorectal Cancer Drugs Market Competitive Situation and Trends
2.7.1 Colorectal Cancer Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Colorectal Cancer Drugs Players Market Share by Revenue
2.7.3 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Colorectal Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Colorectal Cancer Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Colorectal Cancer Drugs Global Colorectal Cancer Drugs Sales by Region: 2018-2029
3.2.1 Global Colorectal Cancer Drugs Sales by Region: 2018-2023
3.2.2 Global Colorectal Cancer Drugs Sales by Region: 2024-2029
3.3 Global Colorectal Cancer Drugs Global Colorectal Cancer Drugs Revenue by Region: 2018-2029
3.3.1 Global Colorectal Cancer Drugs Revenue by Region: 2018-2023
3.3.2 Global Colorectal Cancer Drugs Revenue by Region: 2024-2029
3.4 North America Colorectal Cancer Drugs Market Facts & Figures by Country
3.4.1 North America Colorectal Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Colorectal Cancer Drugs Sales by Country (2018-2029)
3.4.3 North America Colorectal Cancer Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Colorectal Cancer Drugs Market Facts & Figures by Country
3.5.1 Europe Colorectal Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Colorectal Cancer Drugs Sales by Country (2018-2029)
3.5.3 Europe Colorectal Cancer Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Colorectal Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Colorectal Cancer Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Colorectal Cancer Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Colorectal Cancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Colorectal Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Colorectal Cancer Drugs Sales by Country (2018-2029)
3.7.3 Latin America Colorectal Cancer Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Colorectal Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Colorectal Cancer Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Colorectal Cancer Drugs Sales by Type (2018-2029)
4.1.1 Global Colorectal Cancer Drugs Sales by Type (2018-2023)
4.1.2 Global Colorectal Cancer Drugs Sales by Type (2024-2029)
4.1.3 Global Colorectal Cancer Drugs Sales Market Share by Type (2018-2029)
4.2 Global Colorectal Cancer Drugs Revenue by Type (2018-2029)
4.2.1 Global Colorectal Cancer Drugs Revenue by Type (2018-2023)
4.2.2 Global Colorectal Cancer Drugs Revenue by Type (2024-2029)
4.2.3 Global Colorectal Cancer Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Colorectal Cancer Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Colorectal Cancer Drugs Sales by Application (2018-2029)
5.1.1 Global Colorectal Cancer Drugs Sales by Application (2018-2023)
5.1.2 Global Colorectal Cancer Drugs Sales by Application (2024-2029)
5.1.3 Global Colorectal Cancer Drugs Sales Market Share by Application (2018-2029)
5.2 Global Colorectal Cancer Drugs Revenue by Application (2018-2029)
5.2.1 Global Colorectal Cancer Drugs Revenue by Application (2018-2023)
5.2.2 Global Colorectal Cancer Drugs Revenue by Application (2024-2029)
5.2.3 Global Colorectal Cancer Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Colorectal Cancer Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AB Science
6.1.1 AB Science Corporation Information
6.1.2 AB Science Description and Business Overview
6.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AB Science Colorectal Cancer Drugs Product Portfolio
6.1.5 AB Science Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Colorectal Cancer Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Array BioPharma
6.3.1 Array BioPharma Corporation Information
6.3.2 Array BioPharma Description and Business Overview
6.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Array BioPharma Colorectal Cancer Drugs Product Portfolio
6.3.5 Array BioPharma Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Colorectal Cancer Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Elli Lilly
6.6.1 Elli Lilly Corporation Information
6.6.2 Elli Lilly Description and Business Overview
6.6.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elli Lilly Colorectal Cancer Drugs Product Portfolio
6.7.5 Elli Lilly Recent Developments/Updates
6.8 Roch
6.8.1 Roch Corporation Information
6.8.2 Roch Description and Business Overview
6.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Roch Colorectal Cancer Drugs Product Portfolio
6.8.5 Roch Recent Developments/Updates
6.9 Hutchison MediPharma
6.9.1 Hutchison MediPharma Corporation Information
6.9.2 Hutchison MediPharma Description and Business Overview
6.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Hutchison MediPharma Colorectal Cancer Drugs Product Portfolio
6.9.5 Hutchison MediPharma Recent Developments/Updates
6.10 Merck & Co., Inc.
6.10.1 Merck & Co., Inc. Corporation Information
6.10.2 Merck & Co., Inc. Description and Business Overview
6.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Product Portfolio
6.10.5 Merck & Co., Inc. Recent Developments/Updates
6.11 Mologen
6.11.1 Mologen Corporation Information
6.11.2 Mologen Colorectal Cancer Drugs Description and Business Overview
6.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mologen Colorectal Cancer Drugs Product Portfolio
6.11.5 Mologen Recent Developments/Updates
6.12 Regeneron
6.12.1 Regeneron Corporation Information
6.12.2 Regeneron Colorectal Cancer Drugs Description and Business Overview
6.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Regeneron Colorectal Cancer Drugs Product Portfolio
6.12.5 Regeneron Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Colorectal Cancer Drugs Description and Business Overview
6.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sanofi Colorectal Cancer Drugs Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Sumitomo Dainippon
6.14.1 Sumitomo Dainippon Corporation Information
6.14.2 Sumitomo Dainippon Colorectal Cancer Drugs Description and Business Overview
6.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Product Portfolio
6.14.5 Sumitomo Dainippon Recent Developments/Updates
6.15 Taiho Pharmaceutical
6.15.1 Taiho Pharmaceutical Corporation Information
6.15.2 Taiho Pharmaceutical Colorectal Cancer Drugs Description and Business Overview
6.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Product Portfolio
6.15.5 Taiho Pharmaceutical Recent Developments/Updates
6.16 Vaccinogen
6.16.1 Vaccinogen Corporation Information
6.16.2 Vaccinogen Colorectal Cancer Drugs Description and Business Overview
6.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Vaccinogen Colorectal Cancer Drugs Product Portfolio
6.16.5 Vaccinogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Colorectal Cancer Drugs Industry Chain Analysis
7.2 Colorectal Cancer Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Colorectal Cancer Drugs Production Mode & Process
7.4 Colorectal Cancer Drugs Sales and Marketing
7.4.1 Colorectal Cancer Drugs Sales Channels
7.4.2 Colorectal Cancer Drugs Distributors
7.5 Colorectal Cancer Drugs Customers
8 Colorectal Cancer Drugs Market Dynamics
8.1 Colorectal Cancer Drugs Industry Trends
8.2 Colorectal Cancer Drugs Market Drivers
8.3 Colorectal Cancer Drugs Market Challenges
8.4 Colorectal Cancer Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Colorectal Cancer Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Colorectal Cancer Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Colorectal Cancer Drugs Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Colorectal Cancer Drugs Sales (Units) of Key Manufacturers (2018-2023)
    Table 5. Global Colorectal Cancer Drugs Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Colorectal Cancer Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Colorectal Cancer Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Colorectal Cancer Drugs, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Colorectal Cancer Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Colorectal Cancer Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Colorectal Cancer Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Colorectal Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Colorectal Cancer Drugs Sales by Region (2018-2023) & (Units)
    Table 18. Global Colorectal Cancer Drugs Sales Market Share by Region (2018-2023)
    Table 19. Global Colorectal Cancer Drugs Sales by Region (2024-2029) & (Units)
    Table 20. Global Colorectal Cancer Drugs Sales Market Share by Region (2024-2029)
    Table 21. Global Colorectal Cancer Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Colorectal Cancer Drugs Revenue Market Share by Region (2018-2023)
    Table 23. Global Colorectal Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Colorectal Cancer Drugs Revenue Market Share by Region (2024-2029)
    Table 25. North America Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
    Table 27. North America Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
    Table 28. North America Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
    Table 32. Europe Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
    Table 33. Europe Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Colorectal Cancer Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Colorectal Cancer Drugs Sales by Region (2018-2023) & (Units)
    Table 37. Asia Pacific Colorectal Cancer Drugs Sales by Region (2024-2029) & (Units)
    Table 38. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
    Table 42. Latin America Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
    Table 43. Latin America Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
    Table 47. Middle East & Africa Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
    Table 48. Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Colorectal Cancer Drugs Sales (Units) by Type (2018-2023)
    Table 51. Global Colorectal Cancer Drugs Sales (Units) by Type (2024-2029)
    Table 52. Global Colorectal Cancer Drugs Sales Market Share by Type (2018-2023)
    Table 53. Global Colorectal Cancer Drugs Sales Market Share by Type (2024-2029)
    Table 54. Global Colorectal Cancer Drugs Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Colorectal Cancer Drugs Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Colorectal Cancer Drugs Revenue Market Share by Type (2018-2023)
    Table 57. Global Colorectal Cancer Drugs Revenue Market Share by Type (2024-2029)
    Table 58. Global Colorectal Cancer Drugs Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Colorectal Cancer Drugs Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Colorectal Cancer Drugs Sales (Units) by Application (2018-2023)
    Table 61. Global Colorectal Cancer Drugs Sales (Units) by Application (2024-2029)
    Table 62. Global Colorectal Cancer Drugs Sales Market Share by Application (2018-2023)
    Table 63. Global Colorectal Cancer Drugs Sales Market Share by Application (2024-2029)
    Table 64. Global Colorectal Cancer Drugs Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Colorectal Cancer Drugs Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Colorectal Cancer Drugs Revenue Market Share by Application (2018-2023)
    Table 67. Global Colorectal Cancer Drugs Revenue Market Share by Application (2024-2029)
    Table 68. Global Colorectal Cancer Drugs Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Colorectal Cancer Drugs Price (USD/Unit) by Application (2024-2029)
    Table 70. AB Science Corporation Information
    Table 71. AB Science Description and Business Overview
    Table 72. AB Science Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. AB Science Colorectal Cancer Drugs Product
    Table 74. AB Science Recent Developments/Updates
    Table 75. Amgen Corporation Information
    Table 76. Amgen Description and Business Overview
    Table 77. Amgen Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Amgen Colorectal Cancer Drugs Product
    Table 79. Amgen Recent Developments/Updates
    Table 80. Array BioPharma Corporation Information
    Table 81. Array BioPharma Description and Business Overview
    Table 82. Array BioPharma Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Array BioPharma Colorectal Cancer Drugs Product
    Table 84. Array BioPharma Recent Developments/Updates
    Table 85. Bayer Corporation Information
    Table 86. Bayer Description and Business Overview
    Table 87. Bayer Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Bayer Colorectal Cancer Drugs Product
    Table 89. Bayer Recent Developments/Updates
    Table 90. Boehringer Ingelheim Corporation Information
    Table 91. Boehringer Ingelheim Description and Business Overview
    Table 92. Boehringer Ingelheim Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Boehringer Ingelheim Colorectal Cancer Drugs Product
    Table 94. Boehringer Ingelheim Recent Developments/Updates
    Table 95. Bristol-Myers Squibb Corporation Information
    Table 96. Bristol-Myers Squibb Description and Business Overview
    Table 97. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Bristol-Myers Squibb Colorectal Cancer Drugs Product
    Table 99. Bristol-Myers Squibb Recent Developments/Updates
    Table 100. Elli Lilly Corporation Information
    Table 101. Elli Lilly Description and Business Overview
    Table 102. Elli Lilly Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Elli Lilly Colorectal Cancer Drugs Product
    Table 104. Elli Lilly Recent Developments/Updates
    Table 105. Roch Corporation Information
    Table 106. Roch Description and Business Overview
    Table 107. Roch Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Roch Colorectal Cancer Drugs Product
    Table 109. Roch Recent Developments/Updates
    Table 110. Hutchison MediPharma Corporation Information
    Table 111. Hutchison MediPharma Description and Business Overview
    Table 112. Hutchison MediPharma Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Hutchison MediPharma Colorectal Cancer Drugs Product
    Table 114. Hutchison MediPharma Recent Developments/Updates
    Table 115. Merck & Co., Inc. Corporation Information
    Table 116. Merck & Co., Inc. Description and Business Overview
    Table 117. Merck & Co., Inc. Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Merck & Co., Inc. Colorectal Cancer Drugs Product
    Table 119. Merck & Co., Inc. Recent Developments/Updates
    Table 120. Mologen Corporation Information
    Table 121. Mologen Description and Business Overview
    Table 122. Mologen Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Mologen Colorectal Cancer Drugs Product
    Table 124. Mologen Recent Developments/Updates
    Table 125. Regeneron Corporation Information
    Table 126. Regeneron Description and Business Overview
    Table 127. Regeneron Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Regeneron Colorectal Cancer Drugs Product
    Table 129. Regeneron Recent Developments/Updates
    Table 130. Sanofi Corporation Information
    Table 131. Sanofi Description and Business Overview
    Table 132. Sanofi Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Sanofi Colorectal Cancer Drugs Product
    Table 134. Sanofi Recent Developments/Updates
    Table 135. Sumitomo Dainippon Corporation Information
    Table 136. Sumitomo Dainippon Description and Business Overview
    Table 137. Sumitomo Dainippon Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 138. Sumitomo Dainippon Colorectal Cancer Drugs Product
    Table 139. Sumitomo Dainippon Recent Developments/Updates
    Table 140. Taiho Pharmaceutical Corporation Information
    Table 141. Taiho Pharmaceutical Description and Business Overview
    Table 142. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 143. Taiho Pharmaceutical Colorectal Cancer Drugs Product
    Table 144. Taiho Pharmaceutical Recent Developments/Updates
    Table 145. Vaccinogen Corporation Information
    Table 146. Vaccinogen Description and Business Overview
    Table 147. Vaccinogen Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 148. Vaccinogen Colorectal Cancer Drugs Product
    Table 149. Vaccinogen Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Colorectal Cancer Drugs Distributors List
    Table 153. Colorectal Cancer Drugs Customers List
    Table 154. Colorectal Cancer Drugs Market Trends
    Table 155. Colorectal Cancer Drugs Market Drivers
    Table 156. Colorectal Cancer Drugs Market Challenges
    Table 157. Colorectal Cancer Drugs Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Colorectal Cancer Drugs
    Figure 2. Global Colorectal Cancer Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Colorectal Cancer Drugs Market Share by Type in 2022 & 2029
    Figure 4. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture
    Figure 5. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture
    Figure 6. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture
    Figure 7. BRAF or MEK Inhibitors Product Picture
    Figure 8. Tyrosine Kinase (TKI) Inhibitors Product Picture
    Figure 9. Immunomodulators Product Picture
    Figure 10. Global Colorectal Cancer Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 11. Global Colorectal Cancer Drugs Market Share by Application in 2022 & 2029
    Figure 12. Radiotherapy
    Figure 13. Chemotherapy
    Figure 14. Global Colorectal Cancer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Colorectal Cancer Drugs Market Size (2018-2029) & (US$ Million)
    Figure 16. Global Colorectal Cancer Drugs Sales (2018-2029) & (Units)
    Figure 17. Global Colorectal Cancer Drugs Average Price (USD/Unit) & (2018-2029)
    Figure 18. Colorectal Cancer Drugs Report Years Considered
    Figure 19. Colorectal Cancer Drugs Sales Share by Manufacturers in 2022
    Figure 20. Global Colorectal Cancer Drugs Revenue Share by Manufacturers in 2022
    Figure 21. The Global 5 and 10 Largest Colorectal Cancer Drugs Players: Market Share by Revenue in 2022
    Figure 22. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 23. Global Colorectal Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 24. North America Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
    Figure 25. North America Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
    Figure 26. United States Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Canada Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
    Figure 29. Europe Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
    Figure 30. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
    Figure 31. Germany Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. France Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. U.K. Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Italy Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Russia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region (2018-2029)
    Figure 37. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2018-2029)
    Figure 38. China Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Japan Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. South Korea Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. India Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Australia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Taiwan Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Indonesia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Thailand Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Malaysia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Philippines Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Latin America Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
    Figure 49. Latin America Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
    Figure 50. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Argentina Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Middle East & Africa Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
    Figure 54. Middle East & Africa Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
    Figure 55. Turkey Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Saudi Arabia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. U.A.E Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Global Sales Market Share of Colorectal Cancer Drugs by Type (2018-2029)
    Figure 59. Global Revenue Market Share of Colorectal Cancer Drugs by Type (2018-2029)
    Figure 60. Global Colorectal Cancer Drugs Price (USD/Unit) by Type (2018-2029)
    Figure 61. Global Sales Market Share of Colorectal Cancer Drugs by Application (2018-2029)
    Figure 62. Global Revenue Market Share of Colorectal Cancer Drugs by Application (2018-2029)
    Figure 63. Global Colorectal Cancer Drugs Price (USD/Unit) by Application (2018-2029)
    Figure 64. Colorectal Cancer Drugs Value Chain
    Figure 65. Colorectal Cancer Drugs Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Gene Therapy For Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22G13317
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Cancer Biomarkers Detection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-30Q5590
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Oncology Companion Diagnostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14K8500
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Throat Cancer Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8R8713
Fri Feb 23 00:00:00 UTC 2024

Add to Cart